“Sputnik V approval in India will open special privileged strategic partnership,” says Russian Deputy Envoy

Russian Deputy Envoy talks of the outcomes of the approval given to Sputnik V vaccine in India.

As the Russian vaccine, Sputnik V has been approved by the Drug Controller General of India (DCGI) for restricted emergency use, Russian Deputy Envoy considers it a way to open up new dimensions in India-Russia strategic partnership.

In a press conference, on Wednesday, Roman Babushkin, Russian Deputy Envoy, says, “As far as Sputnik vaccine approval is concerned, this is a very significant step because it will open up a new dimension in our special privileged strategic partnership. It would definitely support efforts of vaccination in India,” as quoted by ANI.


Well, Sputnik V is the third Covid vaccine in India, apart from the Covaxin of the Bharat Biotech and Covishield of Oxford AstraZeneca which are being manufactured by the Serum Institute of India. India becomes the 60th country to authorize the use of the Russian vaccine. Amid the surge in Covid cases, approval was given to the Russian vaccine.

Nikolay Kudashev, Russian Ambassador to India mentions the strong relationship between India and Russia. He says, “Our ties remain equal, solid, comprehensive, coherent, and forward-looking despite any global turbulence. They are based on universal principles of interstate relations, international law, UN’s charter and respect of other interests,” as quoted by ANI.

Also, the Russian Foreign Minister was on a two-day visit to India starting from the 5th of April, 2021. On his visit, he met External Affairs Minister S Jayshankar.

Furthermore, it is being anticipated that the approval of Sputnik V will boost up the vaccination in India.